[Pharmacokinetic/pharmacodynamic analysis of anti-hyperprolactinemic effect of terguride based on dopamine D2 receptor occupancy].

Yamada, Yasuhiko; Irizuki, Naoko; Takayanagi, Risa; Yamamoto, Koujirou; Sawada, Yasufumi; Iga, Tatsuji

Yamada, Yasuhiko; Irizuki, Naoko; Takayanagi, Risa; Yamamoto, Koujirou; Sawada, Yasufumi; Iga, Tatsuji.

Affiliation

Yamada Y; Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. yamada-tky@umin.ac.jp

Yakugaku Zasshi ; 123(4): 255-60, 2003 Apr.

Article in Ja | MEDLINE | ID: mdl-12704865

Subject(s)

Hyperprolactinemia/drug therapy; Lisuride/analogs & derivatives; Lisuride/administration & dosage; Lisuride/pharmacokinetics; Receptors, Dopamine D2/metabolism; Administration, Oral; Drug Administration Schedule; Humans; Lisuride/pharmacology; Models, Biological; Pituitary Gland/metabolism; Receptors, Dopamine D2/agonists; Retrospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hyperprolactinemia / Lisuride / Receptors, Dopamine D2 Type of study: Observational_studies Limits: Humans Language: Ja Journal: Yakugaku Zasshi Year: 2003 Document type: Article Affiliation country: Japan Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links